These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7129968)

  • 21. The cytotoxicity of oxalate, metabolite of ethylene glycol, is due to calcium oxalate monohydrate formation.
    Guo C; McMartin KE
    Toxicology; 2005 Mar; 208(3):347-55. PubMed ID: 15695020
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of calcium in the retina by the combined use of ultrastructural cytochemistry and laser microprobe mass analysis.
    Van Reempts JL; Borgers M; De Nollin SR; Garrevoet TC; Jacob WA
    J Histochem Cytochem; 1984 Jul; 32(7):788-92. PubMed ID: 6736627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Crystal-induced kidney disease in 2 kidney transplant recipients.
    Parasuraman R; Venkat KK
    Am J Kidney Dis; 2010 Jan; 55(1):192-7. PubMed ID: 19880229
    [No Abstract]   [Full Text] [Related]  

  • 24. Are calcium oxalate crystals involved in the mechanism of acute renal failure in ethylene glycol poisoning?
    McMartin K
    Clin Toxicol (Phila); 2009 Nov; 47(9):859-69. PubMed ID: 19852621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. CRYSTALS OF CALCIUM OXALATE IN KIDNEYS IN UREMIA.
    FANGER H; ESPARZA A
    Am J Clin Pathol; 1964 Jun; 41():597-603. PubMed ID: 14183049
    [No Abstract]   [Full Text] [Related]  

  • 26. Calcium oxalate monohydrate, a metabolite of ethylene glycol, is toxic for rat renal mitochondrial function.
    McMartin KE; Wallace KB
    Toxicol Sci; 2005 Mar; 84(1):195-200. PubMed ID: 15601675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analyses of long non-coding RNA and mRNA profiling using RNA sequencing in calcium oxalate monohydrate-stimulated renal tubular epithelial cells.
    Wang Z; Zhang JW; Zhang Y; Zhang SP; Hu QY; Liang H
    Urolithiasis; 2019 Jun; 47(3):225-234. PubMed ID: 29947995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extension of a PBPK model for ethylene glycol and glycolic acid to include the competitive formation and clearance of metabolites associated with kidney toxicity in rats and humans.
    Corley RA; Saghir SA; Bartels MJ; Hansen SC; Creim J; McMartin KE; Snellings WM
    Toxicol Appl Pharmacol; 2011 Feb; 250(3):229-44. PubMed ID: 21074520
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dosimetry considerations in the enhanced sensitivity of male Wistar rats to chronic ethylene glycol-induced nephrotoxicity.
    Corley RA; Wilson DM; Hard GC; Stebbins KE; Bartels MJ; Soelberg JJ; Dryzga MD; Gingell R; McMartin KE; Snellings WM
    Toxicol Appl Pharmacol; 2008 Apr; 228(2):165-78. PubMed ID: 18191429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Etiology of calcium oxalate nephrolithiasis in rats. I. Can this be a model for human stone formation?
    de Bruijn WC; Boevé ER; van Run PR; van Miert PP; de Water R; Romijn JC; Verkoelen CF; Cao LC; Schröder FH
    Scanning Microsc; 1995 Mar; 9(1):103-14. PubMed ID: 8553009
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lipid peroxidation in ethylene glycol induced hyperoxaluria and calcium oxalate nephrolithiasis.
    Thamilselvan S; Hackett RL; Khan SR
    J Urol; 1997 Mar; 157(3):1059-63. PubMed ID: 9072543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of etidronate disodium (EHDP) on calcium oxalate renal stones induced by synthetic 1 alpha(OH) vitamin D3 and ethylene glycol in rats].
    Kawamura J; Nonomura M; Okada Y; Yoshida O; Takashima M; Itokawa Y
    Hinyokika Kiyo; 1985 May; 31(5):749-62. PubMed ID: 3931444
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ethylene glycol induces calcium oxalate crystal deposition in Malpighian tubules: a Drosophila model for nephrolithiasis/urolithiasis.
    Chen YH; Liu HP; Chen HY; Tsai FJ; Chang CH; Lee YJ; Lin WY; Chen WC
    Kidney Int; 2011 Aug; 80(4):369-77. PubMed ID: 21451462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral Reference Dose for ethylene glycol based on oxalate crystal-induced renal tubule degeneration as the critical effect.
    Snellings WM; Corley RA; McMartin KE; Kirman CR; Bobst SM
    Regul Toxicol Pharmacol; 2013 Mar; 65(2):229-41. PubMed ID: 23266425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of dietary calcium and magnesium on experimental renal tubular deposition of calcium oxalate crystal induced by ethylene glycol administration and its prevention with phytin and citrate.
    Ebisuno S; Morimoto S; Yoshida T; Fukatani T; Yasukawa S; Ohkawa T
    Urol Int; 1987; 42(5):330-7. PubMed ID: 3433579
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal intratubular crystallisation of calcium oxalate and naftidrofuryl oxalate.
    Moesch C; Rince M; Daudon M; Aldigier JC; Leroux-Robert C
    Lancet; 1991 Nov; 338(8776):1219-20. PubMed ID: 1682637
    [No Abstract]   [Full Text] [Related]  

  • 37. [Intrarenal calcium crystallization. An electron microscopy study].
    Hering F; Burschardt WG
    Urologe A; 1986 Mar; 25(2):116-9. PubMed ID: 3716039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Studies of experimental calcium oxalate stones. 2. The preventive effects of phytin and citrate on renal deposition of calcium oxalate induced by ethylene glycol administration].
    Ebisuno S; Morimoto S; Fukatani T; Miyazaki Y; Yasukawa S; Sawada Y; Ohkawa T
    Nihon Hinyokika Gakkai Zasshi; 1985 Jun; 76(6):843-9. PubMed ID: 4068425
    [No Abstract]   [Full Text] [Related]  

  • 39. Osteopontin is a critical inhibitor of calcium oxalate crystal formation and retention in renal tubules.
    Wesson JA; Johnson RJ; Mazzali M; Beshensky AM; Stietz S; Giachelli C; Liaw L; Alpers CE; Couser WG; Kleinman JG; Hughes J
    J Am Soc Nephrol; 2003 Jan; 14(1):139-47. PubMed ID: 12506146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Citrate, not phosphate, can dissolve calcium oxalate monohydrate crystals and detach these crystals from renal tubular cells.
    Chutipongtanate S; Chaiyarit S; Thongboonkerd V
    Eur J Pharmacol; 2012 Aug; 689(1-3):219-25. PubMed ID: 22713548
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.